VMCS VisualMED Clinical Solutions Corporation (PK)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT

TO SECTION 13 or 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): September 11, 2023

 

InnovaQor, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

Nevada

(State or Other Jurisdiction of Incorporation)

 

000-33191		84-0436055
(Commission File Number)		(I.R.S. Employer Identification No.)

 

400 South Australian Avenue, Suite 800, West Palm Beach, Florida		33401
(Address of Principal Executive Offices)		(Zip Code)

 

(561) 421-1900

(Registrant’s Telephone Number, Including Area Code)

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered under Section 12(b) of the Act:

 

Title of each class		Trading Symbol		Name of each exchange on which registered
None		None		None

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 7.01. Regulation FD Disclosure

 

On September 11, 2023, InnovaQor, Inc. (the “Company”) issued a press release announcing that Darrell Peterson, our Chief Executive Officer, would be interviewed on Uptick Newswire’s “Stock Day” podcast with Matthew Dunehoo. A copy of the press release is attached hereto as Exhibit 99.1 and a transcript of the interview is attached hereto as Exhibit 99.2.

 

The information furnished pursuant to this Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01. Financial Statements and Exhibits

 

(d)

Exhibits

 

Exhibit No.		Exhibit Description
99.1		Press Release dated September 11, 2023
99.2		Transcript of Interview of Darrell Peterson
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: September 15, 2023	INNOVAQOR, INC.
	By:	/s/ Darrell Peterson
		Darrell Peterson
		Chief Executive Officer
		(principal executive officer)

 

 

Exhibit 99.1

 

 

INNOVAQOR, INC. PROVIDES UPDATE AND CONFIRMS DEVELOPMENT OF NEW PRODUCT

 

WEST PALM BEACH, Fla. (September 11, 2023) — InnovaQor, Inc. (OTC: INQR) Chief Executive Officer, Darrell Peterson recently joined Stock Day host Matthew Dunehoo to provide an update and confirm the development of a new product, Curallo.

 

Dunehoo began the interview by asking Peterson to remind his listeners about what InnovaQor does. Peterson provided a brief summary of the healthcare specific software solutions the Company offers, and reminded the audience that these software solutions are fully developed, proven and are marketed by the Company as a SAAS business model.

 

Dunehoo then asked Peterson to describe the Company’s plan to build revenues. Peterson explained that the majority of current revenues were generated from sales of the EHR product in the substance abuse sector and from the provision of IT services. He voiced his belief that the Medical Mime EHR product was better than most of the competition and offered the fasted route to increased, profitable revenues. He further explained that the cost basis could support a multiple of the current number of customers and confirmed the focus on adding new customers. He went on to say that other Company products would receive an increased focus on marketing and would add value to the new platform the Company was building.

 

Dunehoo went on to ask Peterson for more information on this new product that had also been mentioned in recent filings and press releases. Peterson stated that this was probably the most exciting thing that InnovaQor was working on and went on to describe Curallo, a new Medical Professionals Communication Platform solely for the healthcare sector. He further explained that Curallo has been in development since April and that a demonstration should be available in the next few weeks. He stated that Curallo would have a number of free and subscription features but would start with a peer to peer communication platform for healthcare professionals and then expand to offer interactive services for live conferences and training, and include recruitment matching for short and longer term needs in the healthcare sector. He finished by confirming that a new website for Curallo had been launched at www.curallo.com to invite input from prospective users and to provide updates on the status of the project.

 

Dunehoo finished the interview by asking Peterson what message he would like the listeners to take away from today’s show. Peterson responded by confirming that InnovaQor had a significant foundation to build from and repeated his belief that Curallo could create an opportunity for unlimited growth over the next few years. He ended the interview by confirming the Company’s ambition to list on a recognized stock exchange at some time in the future.

 

To hear Darrell Peterson’s entire interview follow the link to the podcast here:

 

https://audioboom.com/posts/8364992-innovaqor-inc-inqr-is-featured-on-the-stock-day-podcast

 

For further information on InnovaQor, Inc., please visit www.innovaqor.com

 

 

About InnovaQor, Inc.

 

InnovaQor delivers innovative technology and software solutions for the medical sector and intends to build a communication platform specifically for the medical sector, which will facilitate communication and collaboration between peers and allow the addition of revenue generating bolt on offers, including existing solutions and a new recruitment matching product for the healthcare sector.

 

Forward-Looking Statements

 

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

 

Contact:

 

Gerard Dab
561 421 1905
press@innovaqor.com

 

 

 

 

Exhibit 99.2

 

InnovaQor, Inc. (INQR) Interview

CEO Darrell Peterson – Uptick News – September 2023

 

Speakers: Matthew Dunehoo and Darrell Peterson

 

Dunehoo: On today’s show we are talking to a Company that has been on before, but today we are speaking to a new CEO for the first time since he assumed the role back in May. The Company is InnovaQor, Inc., that trades on the OTC market under the trading symbol INQR. InnovaQor creates innovative technology solutions that allow medical providers and facilities to effectively enhance their business and processes while protecting their assets and patient data. The new CEO of the Company is Darrell Peterson. Darrell, welcome, onto our show. We look forward to you giving us an update for InnovaQor and hearing your plans for the future.

 

Peterson: Thank you Mathew. It is a pleasure to be on your show and to have the opportunity to provide some updates for your audience and our shareholders.

 

Dunehoo: I know they are ready to hear it so I will go ahead and get right to it. First question, it’s been a while since the Company was last on the show. Would you please take a minute and remind us about exactly what InnovaQor does?

 

Peterson: Of course. InnovaQor owns a number of software solutions specific to the healthcare sector. These solutions include Electronic Health Records software focused on the substance abuse sector, diagnostics interpretation and laboratory information software as well as data mining and interpretation to assist healthcare facilities manage and improve efficiencies and cash flow. These solutions had millions of dollars invested in them, are fully developed and proven, and are marketed by us as a SAAS model.

 

Dunehoo: Excellent, thank you very much. That is an exciting suite of solutions in a very high growth sector as our audience will clearly understand. Can you tell us about your plans to build revenues?

 

Peterson: The majority of our revenue is currently generated from our Medical Mime product and provision of IT services. Medical Mime is an EHR product that is currently focused on the substance abuse sector. We are confident this solution is comparable, and better, with most of our competition and I believe this product offers the fastest route to increased and profitable revenues at this time. Our current cost basis can support a multiple of the number of customers we currently serve and we are currently focusing on adding new customers. Our other products also have an exciting opportunity for increased revenues and will have an increased focus on marketing going forward. All of our products will create an added value and be marketed as a component to an exciting new platform that we are building.

 

Dunehoo: You mentioned this new platform. I have seen your filings and press releases mentioning your plans to build this new platform. Now is the time when you can tell us more about this new platform, please.

 

 

Peterson: Matthew, this is probably the most exciting thing InnovaQor is working on. We have started to build a new platform under the brand name Curallo. It is a Medical Professional’s Network Communication Platform solely for the healthcare sector and will have a number of free and subscription features. We have engaged an external software development team back in April and expect to have a basic demonstration of our platform available in the next few weeks. We will start with a peer to peer communication platform for healthcare professionals and include an interactive service for live conferences and training as well as a recruitment matching service for short or longer-term needs. We have just launched a website at curallo.com to invite input from prospective users and will keep that updated with our progress and launch details.

 

Dunehoo: That’s good to know. It sounds exciting. So much going on. You’ve clearly got a busy time ahead. As we finish up today’s show can I ask you what message you would like our listeners to take away from the show?

 

Peterson: I would like your audience to understand that we have a significant foundation formed and secured, and have embarked on a project that could deliver unlimited opportunity for growth in the next few years. We are currently a fully reporting company listed on the OTC but have an ambition to become listed on a recognized stock exchange at the appropriate time in the future. Thank you for the opportunity to tell your listeners about InnovaQor.

 

Dunehoo: Absolutely Darrell, thanks for being with us today. My guest has been InnovaQor CEO, Darrell Peterson. Again, they trade on the OTC market under the trading symbol INQR. Darrell I’d like to thank you so much for coming on the show, with so much coming down the pike I hope to have you back with us very soon for an update.

 

Peterson: Very well. Thank you and thanks to your audience.

 

 

v3.23.2

Cover	Sep. 11, 2023
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Sep. 11, 2023
Entity File Number	000-33191
Entity Registrant Name	InnovaQor, Inc.
Entity Central Index Key	0001102942
Entity Tax Identification Number	84-0436055
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	400 South Australian Avenue
Entity Address, Address Line Two	Suite 800
Entity Address, City or Town	West Palm Beach
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33401
City Area Code	561
Local Phone Number	421-1900
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false

---